icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
AASLD 2024
Nov 15-19,
San Diego, CA
Back grey_arrow_rt.gif
 
 
 
BULEVIRTIDE MONOTHERAPY MAY REDUCE LIVER DECOMPENSATION IN PATIENTS WITH HDV-RELATED CIRRHOSIS: A CASE-CONTROL STUDY WITH PROPENSITY SCORE WEIGHTED ANALYSIS
 
 
 
AAS:D Nov 15-19 2024
 
E. Degasperi1, A. De Silvestri2, MP. Anolli1, D. Sambarino1, M. Borghi1, R. Perbellini1, F. Facchetti1, R. Soffredini1, S. Monico1, V. De Ledinghen3, S. Metivier4, M. Jachs5, T. Reiberger5, G. D'Offizi6, C. Dietz-Fricke7, G. Papatheodoridis8, MR. Brunetto9, G. Verucchi10, A. Ciancio11, F. Zoulim12, A. Mangia13, MN. Hilleret14, TA. Santantonio15 , N. Coppola16, A. Pellicelli17, B. Roche18, X. Causse19, L. D'Alteroche20, J. Dumortier21, N. Ganne22,
F. Heluwaert23, I. Ollivier24, A. Loglio25, M. Vigaṇ26, A. Federico27, F. Pileri28, M. Maracci29, M. Tonnini30, JP. Arpurt31, K. Barange32, E. Billaud33, S. Pol34, A. Gervais35, A. Minello36, I. Rosa37, M. Puoti38, P. Lampertico1,39

1203241

1203242

1203243

1203244